Moorfields cornea focus 2026
The Moorfields cornea focus meeting is a non-promotional meeting supported by an educational grant from Santen UK and organised and charied by Professor Sajjad Ahmad, Consultant Ophthalmic Surgeon at Moorfields Hospital. Each year the meeting focuses on a different topic.
You can hear more from Mr Ahmad, speaking at the 2025 Cornea focus meeting, by watching the short video below:
The 2026 meeting will be held on 20 November at the Royal Society of Medicine, London, UK and will focus on Ocular Graft versus Host Disease.
We have an exciting agenda featuring a range of expert speakers exploring GvHD; from the pathophysiology of ocular GvHD to novel treatments and the management of systemic GvHD.
This is a hybrid event that you can join in-person at the RSM or virtually via live stream.
Who is the course for?
This course is aimed at ophthalmologists, optmetrists, nurses and allied health professionals wishing to update their knowledge about diseases of the cornea.
Featured topics
- The pathophysiology of Graft versus Host Disease- John Gribben, QMUL, UK
- The pathophysiology of ocular GvHD - Victor Perez, Bascom Palmer Eye Institute, University of Maimi
- The treatment of ocular GvHD - Charles Bouchard, Loyola University Chicago Stritch School of Medicine
- Ocular GvHD in children - Asim Ali, Sick Kids
- Novel treatments in ocular GvHD - Sandeep Jain, University of Illinois Chicago
- The management of systemic GvHD - Jeff Davies, QMUL, UK
- Blood derived products for ocular surface diseases - Jesus Merayo-Lloves,University of Oviedo, Spain
A certificate of attendance will be awarded at the end of the course. CPD certifcation will be applied for, including GOC points.
The Moorfields cornea focus meeting is a non-promotional meeting supported by an educational grant from Santen UK
Book Now
| Date | Location | Time | Seats | Price | |
| 20/11/2026 | In-person at The Royal Society of Medicine, London | 76 | £75.00 | ||
| 20/11/2026 | Online via Zoom | £0.00 |
Taught by
Sajjad Ahmad
Sajjad Ahmad is a Consultant Ophthalmic Surgeon and the Lead for Experimental Medicine at Moorfields Eye Hospital, London, UK. His expertise is in corneal and external eye diseases, particularly inflammatory ocular surface disorders and ocular surface reconstruction. He holds an honorary Associate Clinical Professor position at the Institute of Ophthalmology, University College London, where he runs a laboratory group focusing on corneal stem cell biology and the development of cellular therapies for the eye. Dr Ahmad’s research also investigates translational medicine, analysing drugs, cell therapies and surgical devices for the eye through the regulatory pathway to first-in-human or first-in-eye clinical trials. He is currently running two Phase 1 clinical trials, including a Medical Research Council-funded trial. He is an Ophthalmic Advisor to the European Medicines Agency and the Medicines and Healthcare products Regulatory Agency (MHRA). He also works with the National Institute of Clinical Excellence (NICE) to evaluate ophthalmic therapies for National Health Service (NHS) application.